Related by context. All words. (Click for frequent words.) 64 StromaCel Inc. 64 Gentamicin Surgical Implant 64 Teikoku Pharma USA 64 Xillix 64 Loramyc ™ 64 Cellgate Inc. 63 NeuroMedix 63 Fresenius Biotech 63 AcryMed Incorporated 63 TSX VENTURE CZO 63 InterfeRx 63 commercialize becocalcidiol patented 63 Galderma SA 63 Xphase 63 Loramyc TM 63 Apexigen 63 Vitamin D analogue 63 Selective Electrochemical Tumor Ablation 63 targeted anticancer biopharmaceuticals 63 Ercole Biotech 63 PPTI 63 AltaRex 62 Skin Cholesterol Test 62 Prism Pharmaceuticals 62 Alligator Bioscience AB 62 molecular chaperone regulation 62 CIP TRAMADOL ER 62 PDL# 62 InNexus Biotechnology 62 bioFILM PA TM 62 AkaRx 62 Initiates Enrollment 62 AB OMXS BINV 62 Lumacan 62 Oncobionic 62 Syntonix 62 Inc. AMEX YMI 62 Arno Therapeutics 62 HuMax TAC 62 Æterna Zentaris 62 TRACON Pharmaceuticals 61 SYN X 61 Microbix Biosystems 61 EHT AGN 61 OncoSec 61 X Ceptor 61 Urocidin TM 61 product platforms AZX# 61 Zenvia ™ 61 H3 Pharma 61 TSX VENTURE GAP 61 FluoroPharma 61 commercialize AzaSite 61 RenaZorb TM 61 Rhucin ® recombinant 61 OTCBB PYTO 61 POTELLIGENT R 61 Biolipox 61 Valera Pharmaceuticals 61 Idera Pharmaceuticals 61 Celmed 61 subsidiaries visit http:/www.apricusbio.com 61 Meda STO MEDAA 61 Zor Pharmaceuticals 61 OncoSec Medical 61 AcryMed technologies 61 GenWay Biotech 61 License Option Agreement 61 Crofelemer budesonide foam 61 Creabilis Therapeutics 61 Nasdaq CGEN 61 Alantos 61 proprietary capillary aerosolization 61 Valeant Pharma 61 Transcept Pharmaceuticals 61 Initiates Clinical 61 Oracea TM 61 Receives Milestone Payment 61 subsidiary Embryome Sciences 61 NasdaqGM SPPI 61 Mircette R 61 PrevOnco ™ 61 developing Zerenex ferric 61 Adamis Laboratories 61 Initiates Clinical Trial 60 NovaRx Corporation 60 SEASONALE R 60 Hexvix ® 60 Cerashield ™ 60 TSX VENTURE IGX OTCBB 60 BioGeneriX 60 Ceragenin ™ 60 AzaSite Xtra 60 t2cure GmbH 60 Phusion Laboratories 60 Nasdaq EPCT 60 commercialize pimavanserin 60 WILEX 60 novel emulsion formulation 60 Cellegesic 60 OTCBB HXBM developer 60 acne impetigo 60 candidates Azedra TM 60 Chemokine Therapeutics 60 Antisense Pharma GmbH 60 Neosil 60 COLAZAL R 60 commercialize CK # 60 Pliaglis 60 FOLOTYN ® 60 ZaBeCor 60 Aegera Therapeutics 60 TESARO 60 Completes Patient Enrollment 60 acetonide FA 60 GLASSIA 60 FineTech 60 Paladin Labs 60 Cardium Therapeutics TM 60 Loramyc R 60 Cell Kinetics 60 Oral Calcitonin 60 TM Aganocide 60 Covalon Technologies 60 evaluating satraplatin 60 tiapamil 60 IV Busulfex 60 Sinuwave 60 Neurobionix 60 Bellicum 60 AMEX RGN 60 commercialize Aganocides 60 rxRNA 60 CapGen Offering 60 Initiates Phase II 60 Myocet 60 SansRosa 60 CIMA LABS 60 Georges Gemayel 60 Picchio Pharma Inc. 60 Evoltra ® 60 Therapeutic Competitors companiesandmarkets.com adEgemonye 60 Inc Therapeutic Competitors 60 Revance 60 lead molecular radiotherapeutic 60 Kosan dependence 60 prokinetic agent 60 Nycomed GmbH 60 commercialize XP# 60 Levulan ® PDT 60 CysDisplay 60 Personalized Immunotherapy 60 Prometheus Laboratories 60 Inc. OTCBB SPRX 60 Receive Milestone Payment 60 Syndax 60 successfully commercialize Iluvien 60 Syntonix Pharmaceuticals 60 DermTech International 60 romazarit 60 CombinatoRx Incorporated 60 Engages CHF Investor Relations 60 NASDAQ DYAX 60 Bellicum Pharmaceuticals Inc. 60 PHX# 60 RxKinetix 59 BioSyent Pharma 59 intravesical infusion therapy 59 LEVADEX ™ 59 ActivBiotics 59 Taiho Pharmaceutical 59 Regeneron Pharma 59 AEterna 59 MitoKor 59 Virium 59 pralatrexate injection folate analogue 59 lixivaptan 59 Curacyte AG 59 Eximias Pharmaceutical Corporation 59 Nasdaq PGNX today 59 gastrointestinal disorders ATI 59 Cerashield TM 59 Inflazyme 59 RhuDex ® 59 Zeneus 59 Roche SWX ROG 59 ViroChem Pharma Inc. 59 symbol AVXL 59 manufactures minimally invasive 59 Onalta TM 59 SynthRx 59 Chiral Quest 59 Vernalis plc 59 Igeneon 59 DARA logo 59 AIM SLN Silence 59 Xcytrin R 59 initiate multicenter 59 Medistem Laboratories 59 MultiCell Technologies 59 TransPharma 59 commercialize conjugates consisting 59 Botaneco Specialty Ingredients 59 Raven Biotechnologies 59 Albugon 59 theranostic 59 tramiprosate ALZHEMED TM 59 KAI Pharmaceuticals Inc. 59 Synerx Pharma 59 BioTie 59 Envirokare Tech Inc. 59 GED aPC 59 TIMERx 59 NeutroSpec TM 59 Therapeutic Competitors Companies 59 Announce Merger Agreement 59 mSEPT9 biomarker 59 DP VPA 59 mTCR 59 exclusive sublicense 59 Revotar 59 PrevOnco 59 Chemokine 59 Tekmira Pharmaceuticals Corporation 59 OTCBB NPHC 59 Seikagaku Corporation 59 Increlex TM 59 VCRT 59 FoldRx Pharmaceuticals Inc. 59 NASDAQ PGNX 59 IGXT 59 AMEX REX 59 Emezine 59 ENZON 59 Adamis Pharmaceuticals 59 InvaGen 59 research anddevelopment 59 GTC NASDAQ GTCB 59 Lung Rx 59 Timo Veromaa President 59 elbion GmbH 59 cosmetic cosmeceutical products 59 Vaccinex 59 Sunshine Biopharma 59 ImmuCell Corporation 59 Chrysalin 59 Arbios Systems Inc. 59 markets Testim ® 59 Onco TCS 59 EvoGenix 59 Vantas 59 Prednisporin 59 Cordex Pharma 59 NASDAQ ABII 59 Photodisinfection System 59 Myrexis Inc. 59 Receives CE Marking 59 imaging radiopharmaceuticals 59 Shanghai Medicilon 59 NanoTherapies 59 granting Isotechnika 59 Oracea ® 59 Therapeutic Competitors 59 personalized cellular immunotherapy 59 CyDex Pharmaceuticals 59 Taglich Brothers Initiates Coverage 59 Locteron exclusively 59 Avantome Inc. 59 Captisol ® 59 novel peptides 59 Rozetta Cell 59 Envirokare 59 BTG plc 59 Tibotec BVBA 59 MDxHealth 59 Biovitrum AB 59 Owlstone Nanotech Inc. 59 affiliate Evogene Ltd. TASE 59 Durata Therapeutics 59 Epiphany Biosciences 59 Dermylex TM 59 Symphony Icon 58 Paris IPN Euronext 58 markets HP Acthar 58 Aegera 58 MacroMed 58 NASDAQ NABI 58 SARcode 58 HepeX B 58 Symphony ViDA 58 PregLem 58 MAGE A3 ASCI 58 P#X# antagonist 58 Announces Poster Presentations 58 Onalta 58 Nasdaq IDRA 58 PGL# 58 Thallion Pharmaceuticals 58 SGLT Inhibitors 58 nasal calcitonin product 58 Astellas Deutschland GmbH 58 #,#,# warrants exercisable 58 QUADRAMET R 58 NMP# ® 58 SuperAntibody 58 Exelixis compounds 58 NOBEX 58 TSX OBP 58 Jaiva Technologies 58 Orexo AB 58 targeted radiotherapeutic 58 Tostrex 58 FACTIVE R gemifloxacin 58 TRANSDUR ™ 58 HuCAL antibodies 58 novel immunotherapies 58 Provectus Pharmaceuticals specializes 58 XTLbio 58 POTELLIGENT R Technology 58 OTCBB VCRT 58 AION Diagnostics 58 AIM OBP 58 Nasdaq FURX 58 Solasia 58 Nasdaq CYTR biopharmaceutical 58 ThyroTest R 58 Nasdaq XTLB 58 developing Zerenex TM 58 Welichem 58 Nasdaq HALO biopharmaceutical 58 Receives Approvable Letter 58 BXT # 58 Fludara ® 58 Sunesis Pharmaceuticals 58 Nasdaq RXII 58 NeutroPhase TM 58 OTCBB APCSF 58 Urocidin 58 MINRAD 58 SPL# Gel vaginal microbicide 58 ZARS Pharma 58 CIMAB SA 58 mertansine 58 Targeted Chemotherapy 58 ProEthic Pharmaceuticals 58 Receives ISO #:# [002] 58 Survivin antagonist 58 kidney urologic 58 Tom van Aken 58 Nasdaq IMGN 58 homotaurine 58 Sanvar R 58 non nucleoside inhibitor 58 Dr. Damaj 58 NV Organon 58 Dynogen 58 adult multipotent stem 58 Each Broker Warrant 58 SemEquip 58 Gastrotech 58 PentaStaph 58 Milestone Payment 58 Teikoku Seiyaku Co. 58 Avian Transgenic Technology 58 OMNARIS Nasal Spray 58 Milestone Payments 58 Alvine Pharmaceuticals 58 Submits Response 58 Pharmion Corporation 58 ATL# [002] 58 Dexo 58 Aviptadil 58 vapreotide acetate 58 YONDELIS 58 Cavit Sciences Inc. 58 Retains CCG Investor Relations 58 Fast Track Status 58 Aesthera Corporation 58 platform HDL Mimetic 58 LentiVector technology 58 AMSC Windtec ™ 58 liver resection surgeries 58 Therinject 58 Gemin X Biotechnologies 58 Diatos SA 58 PREVU i 58 Oncolys 58 Biotie 58 Inc. TSX ONC 58 Milestone Payment From 58 ThinPrep System 58 PSMA ADC 58 Sopherion 58 About Positron Positron 58 Oxytrol R 58 Progenitor Cell 58 Allovectin 7 r 58 ImmunoCellular Therapeutics 58 Procyon Biopharma 58 TFChem 58 Predictive medicine 58 OctoPlus licensed 58 Fovea Pharmaceuticals 58 Merck Sante sas 58 CD# CEA 58 MOVIPREP R 58 SYCREST 58 Etubics 58 Nasdaq RGDX 58 Celmed BioSciences 58 Ambrilia Biopharma 58 Genetronics 58 Pegloticase 58 Akorn Strides 58 Nanobody R 58 InB Biotechnologies 58 DepoBupivacaine TM 58 BIOCEUTICALS 58 Galenea 58 TolerRx 58 Private Placement Closed 58 NASDAQ LGND 58 Traficet EN 58 FullTerm 58 TSX VENTURE DMA 58 BioZone Laboratories 58 Nitec 58 NASDAQ ENMD 58 Loramyc 58 ARCALYST R 58 Magnetecs 58 eV PRODUCTS 58 immatics 58 fipamezole 58 sumatriptan DosePro 58 SEASONIQUE 58 ATL# [001] 58 Primera Bioscience 58 Ceragenix 58 Euroscreen 58 EpiCeram 58 EOS NASDAQ MELA 58 Urodynamix Technologies Ltd. 58 Avidex 58 OvaRex ® MAb 58 adenosine injection 58 MelaFind R 58 ENTB 58 Vitaflo Scandinavia AB 58 Emisphere Technologies 58 Portola Pharmaceuticals 58 DOV Pharmaceutical Inc. 58 NIR Diagnostics 58 bendamustine HCl 58 Nventa 58 candidate custirsen 58 aerosolized AAT 58 Licenses Novel 58 Adenosine Therapeutics 58 therapeutic monoclonal antibodies 58 Virulizin 58 Fumapharm 58 methylnaltrexone bromide 58 commercialize Aganocide compounds 58 toenail onychomycosis 58 Generx TM 58 Caprion 58 VaxImmune 58 NASDAQ AEZS TSX AEZ 58 PolyNovo 58 NASDAQ TIWI 58 Zeatin 57 BioNumerik 57 RELISTOR ® 57 OGeS 57 OMAPRO ™ 57 TSX Delisting Review 57 Covalon Technologies Ltd. 57 BioGeneriX AG 57 ONCASPAR 57 miRview meso 57 Othera Pharmaceuticals Inc. 57 TSX VENTURE COV 57 APT Pharmaceuticals 57 Announces Tentative Approval 57 Dr. Manuso 57 ORTHOCON 57 Aradigm Corporation 57 Metaphore 57 ESP Pharma 57 NurOwn 57 RNA antagonists 57 BioControl 57 Due Diligence Period 57 SinuNase ™ 57 Naglazyme R 57 Innodia 57 Xanthus Pharmaceuticals Inc. 57 Phase lll 57 Alvesco R 57 RECOTHROM ® 57 TSX VENTURE PYT 57 Inc. OTCBB ALRX 57 Submits Biologics License Application 57 Procyon Biopharma Inc. 57 Rhein Biotech GmbH 57 Cutanea 57 Inc. OTCBB VODG 57 Trobalt 57 Metabasis stockholders 57 Sigma Tau Pharmaceuticals 57 phase IIb trial 57 Eniluracil 57 small molecule thrombopoietin 57 apaziquone 57 Inc. OTCBB CYGX 57 Nabi HB R 57 Saforis 57 TransVax tm 57 Peyronie disease Frozen Shoulder 57 Altus Pharmaceuticals 57 Akela Pharma 57 OTCBB MMTIF 57 Thallion 57 Genesis Bioventures 57 Modrenal R 57 CRMD# 57 Inc. Nasdaq IMGN 57 E1 INT TM 57 herpetic keratitis 57 LFRP 57 NorDiag 57 Diamyd Medical Diamyd 57 Allovectin 7 57 Salmedix 57 Pancreate 57 Somatuline R Autogel R 57 Carl Spana Ph.D. 57 ONTAK 57 Reports Preclinical Data 57 NDA Submission 57 lexidronam injection 57 TSX VENTURE BVT 57 Vascular Wrap TM 57 VALSTAR 57 Loramyc ® 57 Corautus 57 Senesco Technologies 57 CEQ# 57 YM AIM YMBA 57 Budesonide foam crofelemer 57 JAK2 Inhibitor 57 AMEX ISV 57 Receives Fast Track 57 BioGlue ® 57 ParAllele 57 Synerx 57 NASDAQ HYTM 57 PSD Xetra PSI 57 EGRIFTA TM 57 ChromoCure Inc. 57 TELINTRA R 57 adrenergic regulation 57 OMRIX Biopharmaceuticals 57 NASDAQ CGEN announced 57 Apex Bioventures 57 Alnylam Pharma 57 Phase IIb III 57 Pierre Fabre SA 57 Innovive 57 BioCheck 57 Caleco Pharma 57 Therapeutic Competitors Report 57 RECOTHROM R 57 Idun Pharmaceuticals 57 NTII 57 Presents Preclinical 57 Inc. NASDAQ IDMI 57 PRNewswire FirstCall YM BioSciences 57 David H. Fater 57 Cenomed 57 ZFNs clinical trials 57 coronary stent merged 57 PROLACRIA ™ 57 co licensor KDL 57 Oasmia 57 Veregen R 57 GHIS 57 VIVITROL ® 57 BioPhausia 57 CPL Biologicals 57 Orapred ODT 57 Ipsen SA 57 Inc. OTCBB CYKN 57 Potelligent Technology 57 SynX 57 BayStreet.ca Research Alert 57 Procognia 57 EVIZON TM 57 Zenapax 57 diagnostic radiopharmaceutical 57 MedGenesis 57 R sorafenib tablets 57 Bioniche Pharma Group 57 Liprotamase 57 Inovio AS 57 Orphan Therapeutics 57 commercialize taliglucerase alfa 57 Aeolus Pharmaceuticals 57 molecular imaging radiopharmaceuticals 57 label Lipofen R 57 SNT MC# 57 drug ISA# 57 Nasdaq AVNR 57 Immunotope 57 Receives Orphan Drug Designation 57 Curacyte 57 GERD migraine headaches 57 Aganocide TM 57 SPRIX ® 57 Amorfix 57 delivers fluocinolone acetonide FA 57 Virulizin R 57 XP# XP# 57 Glassia 57 Ipsen Euronext IPN 57 Immunotherapeutic 57 Nuron Biotech 57 Grunenthal GmbH 57 Bio Quant 57 commercialize OncoGenex lead 57 F. Hoffmann LaRoche 57 TSX PTQ OTCBB PTQMF 57 Quark Biotech Inc. 57 Proprius Pharmaceuticals 57 PAION AG 57 Eximias 57 HELSINN 57 Max Neeman International 57 Alinia 57 initiated Phase Ib 57 Anadis Limited 57 ZARS 57 TSX VENTURE TKK Takara 57 IMiDs ® compound 57 Phase #b/#a clinical 57 AeroLEF TM 57 Axcan Pharma Holding BV 57 prostone 57 NUCRYST Pharmaceuticals 57 Urodynamix 57 BioMimetic seeks 57 Inc. Tianlong 57 MagPotash 57 tizanidine hydrochloride short 57 Galderma Pharma 57 Inc. NASDAQ ICGN 57 Hematide ™ 57 please visit www.advaxis.com 57 Helsinn Healthcare SA 57 Flamel Technologies Announces 57 Conatus Pharmaceuticals 57 Dr. Stylli 57 ExonHit Therapeutics SA 57 Bioral Amphotericin B. 57 AMEX DDD 57 muco adhesive technology 57 Potelligent 57 PREOS R 57 NASDAQ OSCI 57 Clavis Pharma 57 SagaX 57 Nippon Shinyaku 57 SUTIMCo 57 GVAX cancer 57 Initiates Clinical Trials 57 IoGen 57 Cellpep 57 candidate deforolimus 57 Gets FDA Clearance 57 oncolytic virus therapies 57 Zemiva TM 57 Oncologix 57 Receives Orphan Drug 57 IMPACS R 57 Medizone International Inc. 57 Auxilium Pharma 57 CANALASKA URANIUM LTD 57 Closes Over Allotment 57 Chronogen 57 Nanobody 57 Active Biotech NASDAQ OMX 57 Orexo 57 CalciMedica 57 developing TB4 57 NASDAQ AEZS 57 IMiDs 57 Cutanea Life Sciences 57 C3 Jian 57 tramiprosate Alzhemed TM 57 Handok Pharmaceuticals 57 OPKO Health 57 Septin 9 57 Psivida 57 Protein Polymer Technologies 57 hyperimmune products 57 Vegenics 57 MCET 57 BioDelivery Sciences 57 RaySearch Laboratories AB publ 57 Advitech 57 Testim R 57 deCODE chemistry 57 Sanochemia 57 Iluvien ® 57 NASDAQ SAMAS 57 Spiegelmer ® 57 STS Biopolymers 57 LUCASSIN 57 IGXT IntelGenx today 57 Submits NDA 57 CINtec R 57 CellGate 57 KNS # 57 WaveForm 57 Glenmark Generics Limited 57 drug GAP #B# 57 GRNVAC1 57 ActivX 57 ZEVALIN ® 57 Bioheart Inc. 57 SOLVAY PHARMACEUTICALS 57 ACLARA 57 PDE4 inhibitor 57 subsidiaries Medicsight PLC 57 XNOM 57 Cara Therapeutics 57 Biotica 57 NASDAQ FLML 57 Evoltra TM 57 VISICOL R 57 candidate Trofex TM 57 Innodia Inc. 57 NitroMist 57 Organichem 57 HaptoGuard 57 Pernix Therapeutics 57 Cx# [002] 57 RhuDex R 57 acyclovir Lauriad R 57 MacroChem 56 Oscient Pharmaceuticals 56 Zirgan 56 NUEDEXTA ™ 56 anti CD3 monoclonal 56 Botaneco 56 MBMI Closes 56 cycle oral contraceptive 56 OVOS Natural Health 56 Prestara 56 FOR FURTHER INFORMATION ABOUT 56 CoTherix 56 non nucleoside HCV 56 Specifid 56 ACTCellerate 56 Cyclacel Pharmaceuticals 56 Karin Eastham 56 Uvidem 56 Gord Froehlich President 56 Frova ® 56 Biotie Therapies Corp. 56 Files IND 56 NASDAQ CYTR biopharmaceutical 56 POWERTECH URANIUM CORP. Powertech 56 TRISENOX ® 56 Quintessence Photonics Corporation 56 Valortim TM 56 POTELLIGENT ® 56 RTP #i 56 telomerase therapeutic 56 Methylphenidate Transdermal System 56 OTCBB IMUC 56 RGIN 56 Granted Orphan Drug 56 Quark Biotech 56 Shigamabs ® 56 dermatology therapies 56 Jenex 56 sirtuin modulators 56 ZEFTERA TM Zevtera TM 56 antibody humanization 56 Nasdaq ONXX today 56 liposomal delivery 56 Vicuron Pharmaceuticals 56 Interface Biologics 56 Cascadero 56 oral taxane 56 Curon Medical 56 Juvaris BioTherapeutics 56 GeneICE 56 Taisho Pharmaceuticals 56 Hapto 56 TSX VENTURE BCG 56 Allovectin 7 R 56 NYSE Amex PTN 56 Molecular Biometrics 56 Thrombin topical Recombinant 56 HuMax 56 AdnaGen 56 JENOPTIK AG 56 OPi 56 TSX PLB 56 Civacir 56 Friedreich Ataxia FRDA 56 MOZOBIL 56 Soliris eculizumab 56 SPO Medical 56 Inc. www.chemaphor.com uses 56 Ecallantide 56 Sanvar 56 SCIB1 56 HemoGenix 56 Development Authority BARDA 56 PORxin TM 56 Genotyping Test 56 Falk Pharma 56 TSX RBM OTCBB 56 Drew Fromkin President 56 SB# ONX 56 EnzymeRx 56 Geomark 56 Caprion Pharmaceuticals Inc. 56 Wafer polifeprosan 56 proprietary bioresorbable polymer 56 Enzon Pharmaceuticals Inc 56 Acrongenomics 56 Response Biomedical Corporation 56 Cytokinetics specified 56 Nasdaq RIGL 56 Transfection Reagent 56 ospemifene 56 underwriters overallotment 56 NuroPro ® 56 MONTREAL CANADA #/#/# 56 Initiate Clinical Trial 56 OTCBB QTXB 56 Submits IND 56 Anidulafungin 56 Ibis T# Biosensor System 56 Response Genetics 56 Elitech 56 Source MDx 56 elbion 56 defensin mimetic antibiotic 56 Ore Pharmaceuticals 56 OLEPTRO 56 Miraculins Announces 56 Vicor anticipates 56 ENGINEERING.com Incorporated Announces 56 Tectin TM 56 arsenic trioxide injection 56 TSX VENTURE URO 56 Investigational Device Exemption 56 Aradigm Logo 56 Ascenta Therapeutics 56 2A receptor agonist 56 proprietary radiolabeled monoclonal 56 MediWound 56 including eniluracil ADH 56 Insert Therapeutics 56 iBioPharma 56 Retacrit 56 AQUA ® 56 NeuroSolutions 56 Phenomix Corporation 56 QuatRx 56 Minaurum 56 LFB Biotechnologies 56 Seikagaku 56 NASDAQ BTRX pharmaceutical 56 Announcement acc 56 AGTC 56 ddRNAi 56 Insmed Incorporated NASDAQ INSM 56 Inc. NASDAQ BPAX 56 Inc. OTCBB IRBS 56 Ivivi 56 www.vivus.com 56 Initiates Phase III 56 QLT Plug Delivery 56 Announce License Agreement 56 NASDAQ OGXI 56 TSX VENTURE KWG 56 Nektar pulmonary 56 oral salmon calcitonin 56 initiate Phase 1b 56 R#/MEM 56 Immuron 56 Cannasat Therapeutics 56 Alton Boynton 56 Validus Pharmaceuticals 56 Juvantia 56 MoxDuo IV 56 Z5 Technologies 56 TSX VENTURE KWG KWG 56 trademarks Vitrasert R 56 Qutenza TM 56 LightLab Imaging 56 PharmaNova 56 AgeChem 56 subsidiary AION Diagnostics 56 TRANSDUR ® 56 pediatric exclusivity 56 Xibrom TM 56 AmpliMed 56 SIX RO ROG 56 Nasdaq CRXL 56 Yellowcake Mining Inc. 56 Biomagnetics Diagnostics Corporation 56 candidates Azedra 56 THALOMID 56 EnVivo 56 Cardioxyl Pharmaceuticals 56 OTC RHHBY 56 Vion Pharmaceuticals 56 Anthony Giovinazzo 56 Prodarsan R 56 Crucell PER.C6 56 TSX VENTURE BTR FRANKFURT 56 DARA BioSciences 56 Georox Resources Inc. 56 IV APAP 56 Xcellerex FlexFactory 56 Aganocide 56 dirucotide MBP# 56 Aphton Corporation 56 granted Ortec 56 iCeutica 56 XL# XL# 56 Atrigel 56 Sulonex TM 56 Kane Biotech 56 Azimuth Opportunity 56 immunotherapies 2A/Furin 56 Oremex Gold 56 BRGO 56 IL# PE#QQR 56 Michael Matvieshen 56 Ltd Therapeutic Competitors 56 Dermylex ™ 56 topical non steroidal 56 ONCONASE R 56 Tyzeka Sebivo 56 VNUS patents 56 Somatuline Depot 56 DOS# 56 CNSX RXE 56 SEQureDx ™ 56 Optical Biopsy System 56 NEBIDO 56 Tikvah Therapeutics 56 DPX Survivac 56 Phase IIb clinical trials 56 Nihon Kohden Corporation 56 Rapinyl 56 rasagiline tablets 56 Nasdaq ALNY 56 Innovive Pharmaceuticals 56 Migenix 56 Nasdaq IDRA today 56 ATG Fresenius S 56 CardioVascular BioTherapeutics Inc. 56 Asentar TM 56 Pharma Merck Serono 56 OTCQB ABPI 56 Syntex Laboratories 56 NASDAQ ABPI 56 ACADIA Pharmaceuticals 56 Obtains Exclusive License 56 G#DT 56 Phase Ib study 56 CYT# potent vascular disrupting 56 Aradigm Corporation OTCBB ARDM 56 Response Genetics Inc. 56 ALN PCS 56 TSX VENTURE COT 56 Gastrointestinal Liner 56 InterfeRx TM 56 Enzo Therapeutics 56 Nascobal 56 Relivar 56 faropenem medoxomil 56 Azmacort R 56 LLSR 56 Amends Agreement 56 Stavzor 56 AMEX ONI 56 Medizone International 56 Solzira